Product Information
LAMOTRIGINE 25 MG DISPER TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1473 per EA under NDC 68462022901. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 19, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462022901
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA079099FDA Approved
2/19/2009
TE Code
AB
On Market Since
2/19/2009
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE 25 MG DISPER TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1473 per EA |
|---|---|
| All-time high | $0.3582 (Jan 13, 2021) |
| All-time low | $0.1206 (Oct 17, 2018) |
| 52-week high | $0.1714 |
| 52-week low | $0.1473 |
| Median price | $0.2281 |
| Average price | $0.2223 |
| Largest weekly change | +54.2% (Dec 19, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 19 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE 25 MG DISPER TAB?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE 25 MG DISPER TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1473 per EA (NDC 68462022901), effective Sep 30, 2026.
How has the price of LAMOTRIGINE 25 MG DISPER TAB changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE 25 MG DISPER TAB has declined 36.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE 25 MG DISPER TAB?
Since Nov 28, 2013, the NADAC for LAMOTRIGINE 25 MG DISPER TAB has ranged from a low of $0.1206 (Oct 17, 2018) to a high of $0.3582 (Jan 13, 2021), with a median of $0.2281 per EA.
Are there cheaper alternatives to LAMOTRIGINE 25 MG DISPER TAB?
Yes. 19 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 25 MG TABLET, is $0.0268 per EA — about 82% below LAMOTRIGINE 25 MG DISPER TAB.
Who manufactures LAMOTRIGINE 25 MG DISPER TAB?
LAMOTRIGINE 25 MG DISPER TAB (NDC 68462022901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.